Yongan Pharmaceutical
Yongan Pharmaceutical Co., Ltd., commonly referred to as Yongan Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of taurine and other amino acids. With a strong operational presence across Asia and beyond, Yongan Pharma is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include taurine-based products, which are distinguished by their purity and efficacy, catering to both health and nutritional sectors. Yongan Pharmaceutical has positioned itself as a leader in the market, achieving notable milestones in product development and regulatory compliance, thereby enhancing its reputation as a trusted supplier in the global pharmaceutical landscape.
DitchCarbon Score
How does Yongan Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yongan Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yongan Pharmaceutical's reported carbon emissions
Yongan Pharmaceutical, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. Yongan Pharmaceutical may be exploring such avenues to align with industry standards and contribute to global climate goals. Further information on their specific commitments or initiatives would be necessary to provide a comprehensive overview.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yongan Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
